Investor mix
1 investor on record; lead investors include Safar Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 100% |
Developer of therapies to treat ocular surface disease
1 investor on record; lead investors include Safar Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 100% |